NQWM
LLY icon

Northwest Quadrant Wealth Management’s Eli Lilly LLY Stock Holding History

Northwest Quadrant Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.29M Sell
2,490
-452
-15% -$458K 0.48% 14
2025
Q4 		$3.16M Buy
2,942
+3
+0.1% +$2.87K 0.65% 11
2025
Q3 		$2.24M Buy
2,939
+3
+0.1% +$2.23K 0.47% 13
2025
Q2 		$2.29M Buy
2,936
+1
+0% +$777 0.51% 13
2025
Q1 		$2.42M Buy
2,935
+6
+0.2% +$4.99K 0.57% 13
2024
Q4 		$2.26M Buy
2,929
+2
+0.1% +$1.66K 0.51% 13
2024
Q3 		$2.59M Buy
2,927
+3
+0.1% +$2.7K 0.6% 12
2024
Q2 		$2.65M Buy
2,924
+3
+0.1% +$2.4K 0.65% 11
2024
Q1 		$2.27M Buy
2,921
+4
+0.1% +$2.85K 0.56% 12
2023
Q4 		$1.7M Buy
2,917
+3
+0.1% +$1.75K 0.44% 14
2023
Q3 		$1.56M Buy
2,914
+4
+0.1% +$2.06K 0.44% 13
2023
Q2 		$1.36M Buy
2,910
+6
+0.2% +$2.52K 0.38% 13
2023
Q1 		$997K Buy
2,904
+7
+0.2% +$2.36K 0.29% 18
2022
Q4 		$1.06M Buy
2,897
+5
+0.2% +$1.77K 0.32% 17
2022
Q3 		$935K Sell
2,892
-545
-16% -$173K 0.31% 18
2022
Q2 		$1.12M Buy
3,437
+257
+8% +$77.1K 0.35% 15
2022
Q1 		$927K Buy
3,180
+7
+0.2% +$1.8K 0.25% 23
2021
Q4 		$876K Buy
3,173
+7
+0.2% +$1.77K 0.24% 22
2021
Q3 		$729K Buy
3,166
+7
+0.2% +$1.73K 0.21% 23
2021
Q2 		$725K Buy
3,159
+6
+0.2% +$1.21K 0.21% 23
2021
Q1 		$589K Sell
3,153
-249
-7% -$48.7K 0.18% 26
2020
Q4 		$568K Buy
3,402
+10
+0.3% +$1.49K 0.19% 24
2020
Q3 		$496K Buy
3,392
+13
+0.4% +$2.01K 0.2% 27
2020
Q2 		$550K Buy
3,379
+14
+0.4% +$2.15K 0.23% 26
2020
Q1 		$515K Sell
3,365
-194
-5% -$26.7K 0.23% 26
2019
Q4 		$467K Buy
3,559
+15
+0.4% +$1.74K 0.19% 30
2019
Q3 		$382K Sell
3,544
-17
-0.5% -$1.89K 0.16% 37
2019
Q2 		$397K Buy
3,561
+16
+0.5% +$1.88K 0.18% 34
2019
Q1 		$458K Buy
3,545
+14
+0.4% +$1.7K 0.21% 28
2018
Q4 		$406K Buy
3,531
+15
+0.4% +$1.68K 0.2% 30
2018
Q3 		$387K Buy
3,516
+16
+0.5% +$1.6K 0.24% 32
2018
Q2 		$299K Buy
3,500
+19
+0.5% +$1.56K 0.2% 40
2018
Q1 		$269K Buy
3,481
+21
+0.6% +$1.69K 0.17% 48
2017
Q4 		$268K Sell
3,460
-85
-2% -$7.23K 0.19% 48
2017
Q3 		$294K Buy
3,545
+19
+0.5% +$1.56K 0.22% 43
2017
Q2 		$289K Sell
3,526
-63
-2% -$5.14K 0.25% 41
2017
Q1 		$290K Buy
3,589
+19
+0.5% +$1.52K 0.28% 43
2016
Q4 		$278K Buy
+3,570
New +$266K 0.29% 45

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Northwest Quadrant Wealth Management's LLY Position: Q1 2026 in Review

Northwest Quadrant Wealth Management reduced its Eli Lilly (LLY) stake by 15% in Q1 2026, selling an estimated $458K and leaving 2,490 shares worth $2.29M. The position accounts for 0.48% of the portfolio, ranked #14.

Northwest Quadrant Wealth Management first reported a position in LLY in Q4 2016 and has held it in 38 quarters since. The position peaked at $3.16M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Northwest Quadrant Wealth Management held 2,490 shares of Eli Lilly worth $2.29M as of Q1 2026.
  • Northwest Quadrant Wealth Management sold 452 Eli Lilly shares in Q1 2026, an estimated $458K.
  • Eli Lilly made up 0.48% of Northwest Quadrant Wealth Management's portfolio in Q1 2026, its #14 holding.
  • Northwest Quadrant Wealth Management first reported a position in Eli Lilly in Q4 2016 and has held it in 38 quarters since.
  • Northwest Quadrant Wealth Management's Eli Lilly position peaked at $3.16M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Northwest Quadrant Wealth Management's 13F filing for Q1 2026, filed 11 May 2026.